Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-08

Clinical Trial Update: The Efficacy of Sodium-glucose Co-transporter 2 Inhibitor or Dipeptidyl Peptidase-4 Inhibitor in Type 2 Diabetes Patients With Premix Insulin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy of a SGLT2 inhibitor or a DPP-4 inhibitor in adults with type 2 diabetes mellitus treated with premixed in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: Type2 Diabetes | Phase 4 | Status: UNKNOWN